Novartis has commenced construction on its new global Biomedical Research centre in San Diego, California, US, aimed at ...

Novo and Hims & Hers have continually locked horns over the legality of obesity drug offerings. Hims & Hers has abandoned ...

Drug developers integrate AI capabilities as a potentially transformative strategy to combat patent cliff losses.

Innovent Biologics and Eli Lilly and Company have entered into a strategic collaboration agreement to accelerate the global ...

One of the world's biggest pharmaceutical distributors will soon be using Ocado's warehouse technology to manage fulfillment.

The rise of smart packaging, how AI is supporting trial acceleration, navigating the pharma supply chain, and more ...

Eli Lilly's Orna acquisition adds to the list of big pharma players hoping to see success from their in vivo cell therapy programmes.

Despite the FDA’s CNPV scheme generating high interest, the process around how voucher awards are prioritised remains unclear.

President Donald Trump has unveiled his TrumpRx website, offering over 40 drugs at steeply discounted prices to cash-paying ...

The London Cancer Hub will act as a global centre for cancer research as the UK looks to maintain competitiveness in the life ...

The guidance, which was published after the European market closed on 3 February, was punished by investors at market open.

SanegeneBio has entered into a $1.5bn global licensing agreement with Genentech, part of the Roche Group, for one of its RNAi ...